La biopsia endomiocardica nella miocardite acuta: Per alcuni ma non per tutti i pazienti

Translated title of the contribution: Endomyocardial biopsy in acute myocarditis: For some but not for all patients

Enrico Ammirati, Manlio Cipriani, Edgardo Bonacina, Andrea Garascia, Fabrizio Oliva

Research output: Contribution to journalArticle

Abstract

Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant- cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.

Original languageItalian
Pages (from-to)539-543
Number of pages5
JournalGiornale Italiano di Cardiologia
Volume16
Issue number10
DOIs
Publication statusPublished - Oct 1 2015

Fingerprint

Myocarditis
Biopsy
Giant Cells
Stroke Volume
Heart Failure
Guidelines

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

La biopsia endomiocardica nella miocardite acuta : Per alcuni ma non per tutti i pazienti. / Ammirati, Enrico; Cipriani, Manlio; Bonacina, Edgardo; Garascia, Andrea; Oliva, Fabrizio.

In: Giornale Italiano di Cardiologia, Vol. 16, No. 10, 01.10.2015, p. 539-543.

Research output: Contribution to journalArticle

Ammirati, E, Cipriani, M, Bonacina, E, Garascia, A & Oliva, F 2015, 'La biopsia endomiocardica nella miocardite acuta: Per alcuni ma non per tutti i pazienti', Giornale Italiano di Cardiologia, vol. 16, no. 10, pp. 539-543. https://doi.org/10.1714/2028.22034
Ammirati, Enrico ; Cipriani, Manlio ; Bonacina, Edgardo ; Garascia, Andrea ; Oliva, Fabrizio. / La biopsia endomiocardica nella miocardite acuta : Per alcuni ma non per tutti i pazienti. In: Giornale Italiano di Cardiologia. 2015 ; Vol. 16, No. 10. pp. 539-543.
@article{4f8b903e673b46e9ac4227e0f318ee85,
title = "La biopsia endomiocardica nella miocardite acuta: Per alcuni ma non per tutti i pazienti",
abstract = "Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant- cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.",
author = "Enrico Ammirati and Manlio Cipriani and Edgardo Bonacina and Andrea Garascia and Fabrizio Oliva",
year = "2015",
month = "10",
day = "1",
doi = "10.1714/2028.22034",
language = "Italian",
volume = "16",
pages = "539--543",
journal = "Giornale Italiano di Cardiologia",
issn = "1827-6806",
publisher = "CEPI s.r.l.",
number = "10",

}

TY - JOUR

T1 - La biopsia endomiocardica nella miocardite acuta

T2 - Per alcuni ma non per tutti i pazienti

AU - Ammirati, Enrico

AU - Cipriani, Manlio

AU - Bonacina, Edgardo

AU - Garascia, Andrea

AU - Oliva, Fabrizio

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant- cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.

AB - Endomyocardial biopsy (EMB) is the gold standard for the diagnosis of myocarditis. Patients with clinical presentation consistent with myocarditis and acute heart failure should undergo EMB, in particular to exclude giant- cell myocarditis or necrotizing eosinophilic myocarditis that are life-threatening conditions. The indication for EMB is debatable in case of suspected myocarditis with infarct-like presentation and preserved left ventricular ejection fraction. In fact, in this group of patients the prognosis is fairly good, and the clinical advantage to reach a histological diagnosis by means of an invasive procedure with potential complications such as EMB is limited. In this article we discuss the indication for EMB in the light of current guidelines based on existing consensus documents.

UR - http://www.scopus.com/inward/record.url?scp=84948149676&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84948149676&partnerID=8YFLogxK

U2 - 10.1714/2028.22034

DO - 10.1714/2028.22034

M3 - Articolo

C2 - 26444211

AN - SCOPUS:84948149676

VL - 16

SP - 539

EP - 543

JO - Giornale Italiano di Cardiologia

JF - Giornale Italiano di Cardiologia

SN - 1827-6806

IS - 10

ER -